Literature DB >> 5487244

In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin.

E Păunescu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5487244     DOI: 10.1038/2281188a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  31 in total

1.  Immunosuppressant activity of the ansamycins.

Authors:  J E Kasik; M Monick; J S Thompson
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

2.  Serologic studies on the occurrence of specific rifampicin antibodies during continuous rifampicin treatment--its frequency and significance.

Authors:  R Kropp; M Krüpe; H Jungbluth
Journal:  Pneumonologie       Date:  1976-04-09

3.  Rifamycins inhibit human neutrophil functions: new derivatives with potential antiinflammatory activity.

Authors:  S Spisani; S Traniello; C Martuccio; O Rizzuti; L Cellai
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

4.  Multiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection.

Authors:  M J Shield; J L Stanford; R C Paul; J W Carswell
Journal:  J Hyg (Lond)       Date:  1977-06

5.  Antibiotics and suppression of lymphocyte function in vitro.

Authors:  G Banck; A Forsgren
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

6.  Suppression of cellular immunity in vivo by rifampicin.

Authors:  G L Floersheim
Journal:  Experientia       Date:  1973-12

7.  Comparison of antibacterial and antiimmune effects of certain rifamycins.

Authors:  J E Kasik; M Monick
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  Effect of rifampin on the immune response in mice.

Authors:  A Bellahsène; A Forsgren
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

9.  3-(Carboxyalkylthio) rifamycin S and SV derivatives inhibit human neutrophil functions.

Authors:  S Spisani; S Traniello; A M Onori; O Rizzuti; C Martuccio; L Cellai
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

10.  The use of an amino acid as a precursor of a bioactive metabolite in combatting an infectious disease: The efficacy of a tryptophan-enriched diet in the treatment of leprosy.

Authors:  J Mauron; R Ganapati; P R Mahadevan; K Anantharaman
Journal:  Amino Acids       Date:  1992-10       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.